Literature DB >> 17952258

[Gender differences among persons with HIV admitted to a university reference center in São Paulo, Brazil].

Patrícia Emilia Braga1, Maria Regina Alves Cardoso, Aluisio Cotrim Segurado.   

Abstract

The number of women living with HIV has increased in Brazil, demanding special attention to women's needs. To evaluate gender differences at an HIV reference center in São Paulo, 1,072 patient medical records from 1998 and 2002 were reviewed. As compared to male counterparts, women tended to be younger and have less schooling, and higher proportions of women were married and heterosexual. Thirty-six percent of women had undergone HIV testing because of an HIV+ partner. In contrast, 43% of men had undergone testing because of AIDS symptoms. At admission, 55% of men and 38% of women had an AIDS diagnosis. Women presented higher CD4+ cell counts and a higher proportion of undetectable HIV viral loads. No difference in access to antiretroviral therapy was seen after stratification for clinical status. Although the observed gender differences in socio-demographic characteristics emphasize women's social vulnerability to HIV, as compared to men, women in this cohort sought specialized care at earlier stages of infection. Knowledge about particular gender characteristics at admission to a reference center may contribute to organizing services delivery, improving care, and maximizing benefits.

Entities:  

Mesh:

Year:  2007        PMID: 17952258     DOI: 10.1590/s0102-311x2007001100013

Source DB:  PubMed          Journal:  Cad Saude Publica        ISSN: 0102-311X            Impact factor:   1.632


  6 in total

1.  Gender-related mortality for HIV-infected patients on highly active antiretroviral therapy (HAART) in rural Uganda.

Authors:  Arif Alibhai; Walter Kipp; L Duncan Saunders; Ambikaipakan Senthilselvan; Amy Kaler; Stan Houston; Joseph Konde-Lule; Joa Okech-Ojony; Tom Rubaale
Journal:  Int J Womens Health       Date:  2010-08-09

2.  Late entry into HIV care: estimated impact on AIDS mortality rates in Brazil, 2003-2006.

Authors:  Alexandre Grangeiro; Maria Mercedes Escuder; Paulo Rossi Menezes; Rosa Alencar; Euclides Ayres de Castilho
Journal:  PLoS One       Date:  2011-01-25       Impact factor: 3.240

3.  HIV testing and clinical status upon admission to a specialized health care unit in Pará, Brazil.

Authors:  Paulo Afonso Martins Abati; Aluisio Cotrim Segurado
Journal:  Rev Saude Publica       Date:  2015-02-27       Impact factor: 2.106

4.  Clinical profile and mortality in patients with T. cruzi/HIV co-infection from the multicenter data base of the "Network for healthcare and study of Trypanosoma cruzi/HIV co-infection and other immunosuppression conditions".

Authors:  Maria Aparecida Shikanai-Yasuda; Mauro Felippe Felix Mediano; Christina Terra Gallafrio Novaes; Andréa Silvestre de Sousa; Ana Marli Christovam Sartori; Rodrigo Carvalho Santana; Dalmo Correia; Cleudson Nery de Castro; Marilia Maria Dos Santos Severo; Alejandro Marcel Hasslocher-Moreno; Marisa Liliana Fernandez; Fernando Salvador; Maria Jesús Pinazo; Valdes Roberto Bolella; Pedro Carvalho Furtado; Marcelo Corti; Ana Yecê Neves Pinto; Alberto Fica; Israel Molina; Joaquim Gascon; Pedro Albajar Viñas; Juan Cortez-Escalante; Alberto Novaes Ramos; Eros Antonio de Almeida
Journal:  PLoS Negl Trop Dis       Date:  2021-09-30

5.  Gender differences in oral manifestations among HIV-infected Brazilian adults.

Authors:  Maria Dongo; Lucio Souza Gonçalves; Sônia Maria S Ferreira; Cesar Werneck Noce; Eliane Pedra Dias; Arley Silva Júnior
Journal:  Int Dent J       Date:  2013-05-14       Impact factor: 2.607

6.  Hepatitis B viremia in HIV-coinfected individuals under antiretroviral therapy.

Authors:  Leonardo Weissmann; Camila de Melo Picone; Michele Soares Gomes Gouvêa; Paulo Roberto Abrão Ferreira; Mônica Salum Valverde Borsoi Viana; João Renato Rebello Pinho; Alex Jones Flores Cassenote; Aluísio Cotrim Segurado
Journal:  Braz J Infect Dis       Date:  2019-11-09       Impact factor: 3.257

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.